354 related articles for article (PubMed ID: 27099785)
1. Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction.
Petrov AM; Kasimov MR; Zefirov AL
Acta Naturae; 2016; 8(1):58-73. PubMed ID: 27099785
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol dysfunction in neurodegenerative diseases: is Huntington's disease in the list?
Valenza M; Cattaneo E
Prog Neurobiol; 2006 Nov; 80(4):165-76. PubMed ID: 17067733
[TBL] [Abstract][Full Text] [Related]
3. Lipid rafts, cholesterol, and the brain.
Korade Z; Kenworthy AK
Neuropharmacology; 2008 Dec; 55(8):1265-73. PubMed ID: 18402986
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol in the Pathogenesis of Alzheimer's, Parkinson's Diseases and Autism: Link to Synaptic Dysfunction.
Petrov AM; Kasimov MR; Zefirov AL
Acta Naturae; 2017; 9(1):26-37. PubMed ID: 28461971
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases.
Vance JE
Dis Model Mech; 2012 Nov; 5(6):746-55. PubMed ID: 23065638
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: a connection between cholesterol metabolism and neurodegeneration.
Goedeke L; Fernández-Hernando C
Neurobiol Dis; 2014 Dec; 72 Pt A():48-53. PubMed ID: 24907491
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
Elife; 2021 Apr; 10():. PubMed ID: 33871358
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.
Dai L; Zou L; Meng L; Qiang G; Yan M; Zhang Z
Mol Neurobiol; 2021 May; 58(5):2183-2201. PubMed ID: 33411241
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol Metabolism in Neurodegenerative Diseases.
He K; Zhao Z; Zhang J; Li D; Wang S; Liu Q
Antioxid Redox Signal; 2024 Jun; ():. PubMed ID: 38842175
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol in myelin biogenesis and hypomyelinating disorders.
Saher G; Stumpf SK
Biochim Biophys Acta; 2015 Aug; 1851(8):1083-94. PubMed ID: 25724171
[TBL] [Abstract][Full Text] [Related]
11. Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism?
Piscianz E; Vecchi Brumatti L; Tommasini A; Marcuzzi A
Neural Regen Res; 2019 Apr; 14(4):582-587. PubMed ID: 30632494
[TBL] [Abstract][Full Text] [Related]
12. Visualisation of cholesterol and ganglioside GM1 in zebrafish models of Niemann-Pick type C disease and Smith-Lemli-Opitz syndrome using light sheet microscopy.
Cook SR; Bladen C; Smith J; Maguire E; Copner J; Fenn GD; Wager K; Waller-Evans H; Lloyd-Evans E
Histochem Cell Biol; 2020 Nov; 154(5):565-578. PubMed ID: 33079236
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptors, nervous system, and lipid metabolism.
Cermenati G; Brioschi E; Abbiati F; Melcangi RC; Caruso D; Mitro N
J Endocrinol Invest; 2013 Jun; 36(6):435-43. PubMed ID: 23609963
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol: its regulation and role in central nervous system disorders.
Orth M; Bellosta S
Cholesterol; 2012; 2012():292598. PubMed ID: 23119149
[TBL] [Abstract][Full Text] [Related]
15. Unraveling the Connection: Cholesterol, Calcium Signaling, and Neurodegeneration.
Casas M; Dickson EJ
Neurosci Insights; 2024; 19():26331055241252772. PubMed ID: 38737295
[TBL] [Abstract][Full Text] [Related]
16. Lipid integration in neurodegeneration: an overview of Alzheimer's disease.
Yadav RS; Tiwari NK
Mol Neurobiol; 2014 Aug; 50(1):168-76. PubMed ID: 24590317
[TBL] [Abstract][Full Text] [Related]
17. Precholesterol sterols accumulate in lipid rafts of patients with Smith-Lemli-Opitz syndrome and X-linked dominant chondrodysplasia punctata.
Rakheja D; Boriack RL
Pediatr Dev Pathol; 2008; 11(2):128-32. PubMed ID: 17378665
[TBL] [Abstract][Full Text] [Related]
18. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
19. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.
Kacher R; Lamazière A; Heck N; Kappes V; Mounier C; Despres G; Dembitskaya Y; Perrin E; Christaller W; Sasidharan Nair S; Messent V; Cartier N; Vanhoutte P; Venance L; Saudou F; Néri C; Caboche J; Betuing S
Brain; 2019 Aug; 142(8):2432-2450. PubMed ID: 31286142
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol in brain disease: sometimes determinant and frequently implicated.
Martín MG; Pfrieger F; Dotti CG
EMBO Rep; 2014 Oct; 15(10):1036-52. PubMed ID: 25223281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
